文献速递肺栓塞与肺血管病

emPHasis-10量表在美国肺动脉高压患者中的健康相关生活质量评估:PHAR登记研究数据

EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR.
PubMed 文献 · Eur Respir J · 2021-02-25

基于美国肺动脉高压协会登记(PHAR)的565例肺动脉高压成人患者数据,评估emPHasis-10(e10)评分与人口学、功能、血流动力学及临床特征的关系,并推导最小重要差值(MID)。e10评分与年龄、教育、收入、吸烟、BMI及6分钟步行距离、BNP/NT-proBNP显著相关,MID估计为-6.0分(范围-5.0至-7.6分)。

要点

  • e10评分与人口学因素(年龄、教育、收入、吸烟、BMI)及临床严重程度指标(6分钟步行距离、BNP/NT-proBNP)相关。
  • 推导出e10评分的MID估计为-6.0分(范围-5.0至-7.6分)。
  • e10评分可用于评估肺动脉高压患者健康相关生活质量,受社会因素和疾病严重程度共同影响。

核心结论

  • e10评分与人口学和临床特征相关,提示肺动脉高压健康相关生活质量受社会因素和疾病严重程度影响。

研究设计与样本

  • 利用美国肺动脉高压协会登记(PHAR)数据,分析565例肺动脉高压成人患者(75%女性,平均年龄55.6±16.0岁)的e10评分与基线及纵向临床特征的关系,并推导MID。

主要发现

  • 基线时e10评分与年龄、教育水平、收入、吸烟状态和体重指数显著相关。
  • 6分钟步行距离和BNP/NT-proBNP在基线和纵向均与e10评分显著相关。
  • e10评分的MID估计为-6.0分(范围-5.0至-7.6分)。

临床怎么用

  • e10评分可用于评估肺动脉高压患者健康相关生活质量,需结合社会因素和疾病严重程度综合解读。

局限性

  • 未来需要研究证明e10评分对临床决策的影响及其在评估临床重要干预中的潜在效用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: While the performance of the emPHasis-10 (e10) score has been evaluated against limited patient characteristics within the United Kingdom, there is an unmet need for exploring the performance of the e10 score among pulmonary arterial hypertension (PAH) patients in the United States. METHODS: Using the Pulmonary Hypertension Association Registry, we evaluated relationships between the e10 score and demographic, functional, haemodynamic and additional clinical characteristics at baseline and over time. Furthermore, we derived a minimally important difference (MID) estimate for the e10 score. RESULTS: We analysed data from 565 PAH (75% female) adults aged mean±sd 55.6±16.0 years. At baseline, the e10 score had notable correlation with factors expected to impact quality of life in the general population, including age, education level, income, smoking status and body mass index. Clinically important parameters including 6-min walk distance and B-type natriuretic peptide (BNP)/N-terminal proBNP were also significantly associated with e10 score at baseline and over time. We generated a MID estimate for the e10 score of -6.0 points (range -5.0--7.6 points). CONCLUSIONS: The e10 score was associated with demographic and clinical patient characteristics, suggesting that health-related quality of life in PAH is influenced by both social factors and indicators of disease severity. Future studies are needed to demonstrate the impact of the e10 score on clinical decision-making and its potential utility for assessing clinically important interventions.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Borgese M, Badesch D, Bull T, et al. EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR. Eur Respir J. 2021. PMID: 33243844. doi:10.1183/13993003.00414-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。